Transplanted hepatocytes integrate, survive, and express their specific functions in the liver parenchyma. The aim of this study was to determine whether a large number of hepatocytes could move from the spleen to the liver when the cells are injected together with sodium nitroprusside, and if the improved hepatocyte migration may be related with portal vein dilatation. Wistar rats were transplanted in the spleen with fluorescent-labeled hepatocytes alone or together with sodium nitroprusside. At 1, 3, 6, and 24 h after the transplant, the liver from recipient animals was removed and morphometric analyses were performed. Portal and arterial pressures were also measured immediately after intrasplenic injection of a solution of sodium nitroprusside, hepatocytes alone, or hepatocytes plus sodium nitroprusside. Intrasplenically injected sodium nitroprusside produced a transient drop in arterial pressure and a sustained reduction in portal pressure. During hepatocyte transplantation it increased the number of transplanted cells migrating to the liver after 3 h. Sodium nitroprusside simultaneously injected with hepatocytes in the spleen allowed more cells to migrate into the liver of the host animal without risk in animal survival.
ArkadopoulosN.; LiljaH.; SuhK. S.; DemetriouA. A.; RozgaJ.Intrasplenic transplantation of allogeneic hepatocytes prolongs survival in anhepatic rats.Hepatology28(5): 1365–1370; 1998.
2.
BrandtM. L.; EckertJ. W.; BuerkleC. J.; FinegoldM. J.The subcutaneous spleen: A new model for percutaneous access to the portal venous system.J. Invest. Surg.9: 161–166; 1996.
3.
BriandD.; CentenoD.; AstreC.; Saint AubertB.; JoyeuxH.Comparison of two methods of autologous intrasplenic hepatocellular transplantation in partially hepatectomized dogs.Eur. Surg. Res.25: 104–109; 1993.
4.
De RoosW. K.; Von GeusauB. A.; BouwmanE.; Van DierrendonckJ. H.; Borel RinkesI. H. M.; TerpstraO. T.Monitoring engraftment of transplanted hepatocytes in recipient liver with 5-bromo-2′-deoxyuridine.Transplantation63(4): 513–518; 1997.
5.
FoxI. J.Transplantation into and inside the liver.Hepatology36(1): 249–251; 2002.
6.
FoxI. J.; ChowdhuryJ. R.; KaufmanS. S.; GoertzenT. C.; ChowdhuryN. R.; WarkentinP. I.; DarkoK.; SauterB. V.; StromS. C.Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation.N. Engl. J. Med.338(20): 1422–1426; 1998.
7.
FujiokaH.; HuntP. J.; RozgaJ.; WuG. D.; CramerD. V.; DemetriouA. A.; MoscioniA. D.Carboxyfluorescein (CFSE) labelling of hepatocytes for short-term localization following intraportal transplantation.Cell Transplant.3(5): 397–408; 1994.
8.
GuptaS.; RajvanshiP.; SokhiR.; SlehriaS.; YamA.; KerrA.; NovikoffP. M.Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium.Hepatology29(2): 509–519; 1999.
KobayashiN.; ItoM.; NakamuraJ.; CaiJ.; HammelJ. M.; FoxI. J.Treatment of carbon tetrachloride and phenobarbital-induced chronic liver failure with intrasplenic hepatocyte transplantation.Cell Transplant.9(5): 671–673; 2000.
11.
MakowkaL.; RotsteinL. E.; FalkR. E.; FalkJ. A.; LangerB.; NossalN. A.; BlendisL. M.; PhillipsM. J.Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic, and xenogeneic hepatocyte transplantation.Surgery88(2): 244–253; 1980.
12.
MalhiH.; AnnamaneniP.; SlehriaS.; JosephB.; BhargavaK. K.; PalestroJ. C.; NovikoffP. M.; GuptaS.Cyclophosphamide disrupts hepatic sinusoidal endotelium and improves transplanted cell engraftment in rat liver.Hepatology36(1): 112–121; 2002.
13.
NietoJ. A.; EscandónJ.; BetancorC.; RamosJ.; CantónT.; Cuervas-MonsT.Evidence that temporary complete occlusion of splenic vessels prevents massive embolization and sudden death associated with intrasplenic hepatocellular transplantation.Transplantation47: 449–450; 1989.
14.
NiknahadH.; O'BrienP. J.Involvement of nitric oxide in nitroprusside-induced hepatocyte cytotoxicity.Biochem. Pharmacol.51: 1031–1039; 1996.
15.
OatesJ. A.Antihypertensive agents and the drug therapy of hypertension. In: Goodman & Gilman's the pharmacological basis of therapeutics (9th ed., Int. Ed.). New York: McGraw-Hill; 1996: 781–808.
RajvanshiP.; KerrA.; BhargavaK. K.; BurkR. D.; GuptaS.Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents.Gastroenterology111: 1092–1102; 1996.
18.
RiordanS. M.; WilliamsR.Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis.J. Gastroenterol. Hepatol.14(8): 757–770; 1999.
19.
RodriguezJ. V.; GuibertE. E.; QuintanaA.; ScandizziA.; AlmadaL.Role of sodium nitroprusside in the improvement of rat liver preservation in University of Wisconsin solution: A study in the isolated perfused liver model.J. Surg. Res.87: 201–208; 1999.
20.
SeglenP. O.Preparation of isolated rat liver cells.Methods Cell Biol.13: 29–83; 1976.
21.
SlehriaS.; RajvanshiP.; ItoY.; SokhiR.; BhargavaK. K.; PalestroC. J.; McCuskeyR. S.; GuptaS.Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver.Hepatology35(6): 1320–1328; 2002.
22.
SpinelliS.; RodriguezJ. V.; QuintanaA. B.; MediavillaM. G.; GuibertE. E.Engraftment and function of intrasplenically transplanted cold stored hepatocytes.Cell Transplant.11(2): 161–168; 2002.
23.
StromS. C.; ChowdhuryJ. R.; FoxI. J.Hepatocyte transplantation for the treatment of human disease.Semin. Liver Dis.19(1): 39–48; 1999.
